Drug · DIN 02478331
TEVA-DASATINIB
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 5, 2021; first marketed May 5, 2021.
- Drug Identification Number (DIN)
- 02478331
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Dasatinib L01EA02
- Class
- Human
- Record last updated
- February 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DASATINIB (DASATINIB MONOHYDRATE) | 80 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 14, 2020: NOC 23444Abbreviated New Drug Submission (ANDS)
Other DINs named TEVA-DASATINIB
- DIN 02478307 · Marketed
- DIN 02478315 · Marketed
- DIN 02478323 · Marketed
- DIN 02478358 · Marketed